In episode 25 of "The Conversational Flow" podcast, guest David Leclerc, Director of the Cytometry and Antibody Technology (CAT) Facility at the University of Chicago, joins Dom and John to share his professional journey and insights into the evolving world of flow cytometry. Leclerc reflects on his early struggles during his master’s program in Montreal and how those challenges ultimately led him to a fulfilling career in core facility management and leadership. The discussion transitions to explore microfluidics as a potential future direction for the field, and whether these new technologies truly qualify as flow cytometry, emphasizing that innovations like acoustic focusing and new sorting platforms are improving both speed and data quality. The conversation broadens to compare academic and industrial (CRO) perspectives, highlighting differences in technology adoption, automation, and data reproducibility.
“The Conversational Flow” an official podcast of KCAS Bio, and focuses on the more niche topic of Flow Cytometry and its role within the greater pharmaceutical, biopharmaceutical and bioanalytical industries. Every month, KCAS Bio will bring you another 60 minutes (or so) of friendly banter between our two finest Flow Cytometry experts as they chat over coffee and discuss what they’ve learned about the world of Flow Cytometry the past couple of weeks. “The Conversational Flow” is brought to you by KCAS Bio.
KCAS Bio is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA, and Lyon, France, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the pharmaceutical, biopharmaceutical, animal health and medical device industries.